👋 New here? A quick tour of the page
📂
Sector tabs
Filter the analysis to a single sector, or stay on the first tab for the full market scan.
📈
Stock cards
Stocks ranked by positive mentions × average sentiment. Open "Why is it moving?" on any card to read the exact headlines behind the score — each one links to its original article.
🔍
Search a stock
Use the sidebar search to look up any tracked ticker or company name and see its bullish and bearish headlines side by side.
📡
Refresh & custom feeds
Hit Refresh Analysis to re-scan the latest news, or add your own RSS feed in the sidebar to include it in the scan.
Healthcare picks
Ranked by positive mention count × average VADER sentiment score.
LLY
0.559
$1410.99
▼
0.46%
41 mentions
Why is LLY moving?
▲ Why it may be rising
- CNBC Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs They're the latest metrics on how much the new Me…
- trefis.com Could You Have Seen Merck Stock's Pipeline Run Coming? Merck (MRK) stock gained about 89% in the year from mid-September 2025, against a 17.1% price gain for th…
- Yahoo Finance Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?
▼ Why it may be falling
- fool.com Eli Lilly Stock Is On Track to Do Something It Hasn't Done Since 2016 The top healthcare stock has been underperforming the market, and its returns haven't been…
- MarketWatch This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month Viking Therapeutics is developing VK2735, a…
- Yahoo Finance Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round
PFE
0.412
$30.67
▲
0.49%
20 mentions
Why is PFE moving?
▲ Why it may be rising
- Nasdaq Is Pfizer an Excellent Dividend Stock to Buy? Pfizer (NYSE: PFE) has experienced unprecedented circumstances in the previous decade.
- Investing.com Pfizer to share overseas drug revenue with HHS under pricing deal
- Yahoo Finance Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?
▼ Why it may be falling
- trefis.com Was Moderna Stock's Cancer Vaccine Run Visible In Advance? Moderna (MRNA) stock rose roughly 510% over the year to September 21, 2026, climbing from about $25 t…
- Nasdaq Pfizer's Tilrekimig Meets Phase 2 Primary Endpoint In Atopic Dermatitis (RTTNews) - Pfizer Inc. (PFE) reported Thursday that its ongoing Phase 2 study of invest…
- Nasdaq Here's Exactly Why I'm Not Afraid of Pfizer's 6% Dividend Yield Key PointsPfizer shares have underperformed since 2021, with the recent poor performance reflect…
JNJ
0.514
$270.56
▼
0.97%
19 mentions
Why is JNJ moving?
▲ Why it may be rising
- Nasdaq Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal Key PointsJohnson & Johnson announ…
- trefis.com Could You Have Seen Merck Stock's Pipeline Run Coming? Merck (MRK) stock gained about 89% in the year from mid-September 2025, against a 17.1% price gain for th…
- Nasdaq AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? Key PointsAbbVie continues to diversify its portfolio into neuroscience and aesthe…
▼ Why it may be falling
- trefis.com Was The Run In JNJ Stock Hiding In Plain Sight? Johnson & Johnson (JNJ) stock returned around 52% in the twelve months, against 17% for the S&P 500. A $10,000 h…
- Nasdaq J&J's Tremfya Shows Sustained Remission In Crohn's Disease Through 3 Years (RTTNews) - Johnson & Johnson (JNJ) reported three-year data showing sustained clinic…
- Yahoo Finance Health Bellwether J&J Slumps As Middle East Conflict Hampers Medtech Sales Johnson & Johnson stock fell early Tuesday as the conflict in the Middle East weighte…
ABBV
0.544
$288.84
▼
2.05%
18 mentions
Why is ABBV moving?
▲ Why it may be rising
- Yahoo Finance AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?
- Nasdaq AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now? Key PointsAbbVie's Qulipta could be racing toward another label…
- Nasdaq Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade Key PointsAbbVie has increased its dividend for 53…
▼ Why it may be falling
- Yahoo Finance Stock Market Today: Dow Cuts Sharp Losses As Some Techs Rally; AbbVie Breaks Out (Live Coverage) The Dow Jones index drops 500 points Wednesday as Treasury yiel…
- Nasdaq How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? Key PointsAmgen, Pfizer, J&J, AbbVie, and Bristol Myers Squi…
- Nasdaq AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? Key PointsAbbVie is aggressively diversifying its pipeline to mitigate the revenue impa…
MRNA
0.504
$220.83
▼
0.40%
17 mentions
Why is MRNA moving?
▲ Why it may be rising
- Fortune Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug CI is pairing top AI and bi…
- MarketWatch Citi tells investors it’s time to sell Moderna after 600%-plus stock gains Revenue and profit forecasts fail to justify the hype baked into Moderna’s share pric…
- investorshub.advfn.com Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility Shares of Novavax Inc (NASDAQ:NVAX) and Moderna Inc (NASDAQ:MRNA) declined on Wednesd…
▼ Why it may be falling
- trefis.com Was Moderna Stock's Cancer Vaccine Run Visible In Advance? Moderna (MRNA) stock rose roughly 510% over the year to September 21, 2026, climbing from about $25 t…
- Yahoo Finance Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell. Citi downgrades Moderna to Sell from Hold, saying the data around its cancer vacci…
- thestreet.com Citi delivers major verdict after Moderna’s remarkable 703% run Moderna’s rally has priced in unrealistic expectations for its cancer drug sales.
MRK
0.517
$148.36
▼
0.78%
13 mentions
Why is MRK moving?
▲ Why it may be rising
- Yahoo Finance Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?
- trefis.com Could You Have Seen Merck Stock's Pipeline Run Coming? Merck (MRK) stock gained about 89% in the year from mid-September 2025, against a 17.1% price gain for th…
- Nasdaq Merck Signs $2.13 Bln License Deal With SciBrunch Therapeutics For KRAS G12D Inhibitor (RTTNews) - Merck & Co., Inc. (MRK), an American multinational pharmaceut…
▼ Why it may be falling
- trefis.com Was Moderna Stock's Cancer Vaccine Run Visible In Advance? Moderna (MRNA) stock rose roughly 510% over the year to September 21, 2026, climbing from about $25 t…
- CNBC Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make His comments come after Merck officially opened its new 120,000-square-fo…
- CNBC Moderna shares plunge after cancer vaccine data leaks — despite positive results Moderna released full data on its closely watched cancer vaccine developed with…
AMGN
0.632
$465.45
▼
0.12%
11 mentions
Why is AMGN moving?
▲ Why it may be rising
- Yahoo Finance Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?
- Nasdaq 2 Healthcare Stocks That Just Delivered Great News for Investors Key PointsVertex Pharmaceuticals and Amgen recently posted strong clinical trial results for pr…
- Nasdaq Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026? Key PointsAmgen offers a diversified portfolio of established therapies across on…
▼ Why it may be falling
- Nasdaq How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? Key PointsAmgen, Pfizer, J&J, AbbVie, and Bristol Myers Squi…
- trefis.com Is Amgen Stock Increasing Your Market Risk? Investors holding shares of Amgen (AMGN), the $234 billion maker of drugs such as Repatha and Prolia, likely pair th…
- CNBC Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer A drug from Amgen could give patients with an aggressive form of lung ca…
UNH
0.514
$400.44
▼
1.60%
10 mentions
Why is UNH moving?
▲ Why it may be rising
- Nasdaq Should You Buy UnitedHealth Group Stock Before Oct. 13? Key PointsUnitedHealth's stock has been doing much better this year due to improved financial results.
- trefis.com Did UnitedHealth Name The Fix Before Its Stock Ran? UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 5…
- Nasdaq Is UnitedHealth Stock an Undervalued Stock to Buy Right Now? The business is recovering faster than expected as management's policies are improving operations.
▼ Why it may be falling
- trefis.com How Much Downside Is Left In CVS Health Stock? CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Eleva…
- Yahoo Finance UnitedHealth Earnings Beat Wall Street Estimates. The Turnaround Continues. Spending on medical costs—a pain point for large insurers in recent years—continues…
- Nasdaq UnitedHealth: 3 Key Takeaways for Long-Term Investors Key PointsAI chart summarization expanded to 40% of clinicians, cutting review time by 33%.
BMY
0.483
$63.02
▲
0.86%
10 mentions
Why is BMY moving?
▲ Why it may be rising
- Nasdaq Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? Key PointsBristol Myers Squibb's Growth Portfolio sales rose 15% in the s…
- Nasdaq AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? Key PointsAbbVie continues to grow its revenue base by successfully transitioni…
- fool.com Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy? Bristol Myers Squibb isn't a growth stock, but it may offer somethin…
▼ Why it may be falling
- Nasdaq 3 Numbers That Explain Bristol Myers Squibb's Dirt Cheap Valuation Key PointsBristol Myers Squibb's stock price is up 42.5% in the past 12 months, yet it still…
- Nasdaq How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? Key PointsAmgen, Pfizer, J&J, AbbVie, and Bristol Myers Squi…
- Nasdaq Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait. Key PointsBristol Myers Squibb has a moderately high forward dividend yield, but that…
ABT
0.614
$110.16
▲
3.73%
9 mentions
Why is ABT moving?
▲ Why it may be rising
- Nasdaq Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth Key PointsAbbott Laboratories generated a higher to…
- Nasdaq 3 High-Yielding Dividend Stocks That Are No-Brainer Buys for Retirees and Risk-Averse Investors Key PointsExxonMobil, McDonald's, and Abbott Laboratories are le…
- Yahoo Finance What Makes Abbott Laboratories (ABT) an Attractive Opportunity? Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the let…
▼ Why it may be falling
- Investing.com Texas diesel hits record $5.97 as Abbott disaster declaration rattles VLO, PSX pre-market
- Investing.com Abbott options flow points to downside caution after guidance cut
- Yahoo Finance Abbott to Spin Off Troubled Nutrition Unit to Focus on Growth Abbott Laboratories plans to separate its global nutrition business into an independent, publicly…
GILD
0.597
$170.33
▼
0.21%
8 mentions
Why is GILD moving?
▲ Why it may be rising
- Yahoo Finance Why Morgan Stanley likes Gilead's HIV prevention play
- Yahoo Finance Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive? Gilead Sciences, Inc. (NASDAQ:GILD) has had a considerably better year than the broa…
- MarketWatch Big pharma stocks close near all-time highs as tech selloff pushes investors toward safer bets Shares of AbbVie, Eli Lilly and Gilead Sciences closed near recor…
ISRG
0.555
$436.87
▲
1.12%
8 mentions
Why is ISRG moving?
▲ Why it may be rising
- Nasdaq Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth Key PointsAbbott Laboratories generated a higher to…
- Yahoo Finance Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? ISRG's rapid procedure growth, expanding robotics ecosystem and recurring revenues hi…
- trefis.com Can This Number Push ISRG Stock Higher? Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has f…
CVS
0.534
$88.51
▼
1.93%
7 mentions
Why is CVS moving?
▲ Why it may be rising
▼ Why it may be falling
- trefis.com How Much Downside Is Left In CVS Health Stock? CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Eleva…
- Yahoo Finance Is the economy awful? S&P 500 and job market say otherwise Yahoo Finance Executive Editor Brian Sozzi examines the latest economic indicators, including how low…
- trefis.com What Could Stop CVS Health Stock Over The Next Six Months? For questions about this article or underlying research, email help@trefis.com.
ZTS
0.355
$83.18
▲
4.34%
7 mentions
Why is ZTS moving?
▲ Why it may be rising
- Nasdaq Zoetis (ZTS) Shares Cross 3% Yield Mark Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of Zoetis Inc (Symbol: ZTS)…
- Yahoo Finance Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note In the most recent trading session, Zoetis (ZTS) closed at $70.27, indicating a -1…
- Yahoo Finance Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why Zoetis (ZTS) reached $69.1 at the closing of the latest trading day, reflecting a -1.05% change compared to…
VRTX
0.712
$553.15
▼
1.03%
6 mentions
Why is VRTX moving?
▲ Why it may be rising
- Nasdaq 2 Healthcare Stocks That Just Delivered Great News for Investors Key PointsVertex Pharmaceuticals and Amgen recently posted strong clinical trial results for pr…
- Nasdaq Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026? Key PointsAmgen offers a diversified portfolio of established therapies across on…
- Yahoo Finance Andrew Hill Investment Fund Sees More Growth Ahead for Vertex (VRTX): Here’s Why Andrew Hill Investment Advisors recently released its third-quarter 2026 invest…
REGN
0.456
$961.26
▲
3.60%
5 mentions
Why is REGN moving?
▲ Why it may be rising
- Nasdaq Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30? Key PointsRegeneron's stock has underperformed the market this year, but it got a boost last time…
- Nasdaq Sanofi & Regeneron Expand Alliance With Four Next-Gen Antibodies (RTTNews) - On Thursday, Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announced the expans…
- Nasdaq Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share Key PointsRegeneron’s revenue is growing at a good clip despite declining…
BSX
0.388
$44.32
▲
5.57%
5 mentions
Why is BSX moving?
▲ Why it may be rising
- trefis.com How Big Could BSX Stock's Next Fall Be? Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0…
- Yahoo Finance Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know In the latest trading session, Boston Scientific (BSX) closed at $42.6, marking a -1.4…
- trefis.com Can Boston Scientific Stock Bounce Off This Support Again? For questions about this article or underlying research, email help@trefis.com.
▼ Why it may be falling
MDT
0.287
$99.29
▲
2.85%
5 mentions
Why is MDT moving?
▲ Why it may be rising
- Nasdaq Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway? Key PointsAt the current share price, Medtronic's divid…
- Investing.com Medtronic gains regulatory clearances for cardiac software
- Nasdaq 2 High-Yield Stocks to Buy in October Without Any Hesitation Key PointsMedtronic's revenues grow nearly 14% in the fiscal first quarter of 2027.
▼ Why it may be falling
- Nasdaq Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There? Key PointsMedtronic struggled with macro, operational, and fo…
- Yahoo Finance Is it Apt to Retain Medtronic Stock in Your Portfolio Now? MDT expands in cardiac ablation, robotics, hypertension and digital surgery, but tariff, inflation an…
CAH
0.41
$254.33
▲
1.54%
4 mentions
Why is CAH moving?
▲ Why it may be rising
LH
0.626
$355.59
▼
1.60%
3 mentions
Why is LH moving?
▲ Why it may be rising
- Nasdaq Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 Mln (RTTNews) - Laboratory services provider LabCorp Holdings Inc. (LH) announced on Tuesday…
- Nasdaq Labcorp Holdings Inc. Announces Rise In Q3 Profit (RTTNews) - Labcorp Holdings Inc. (LH) revealed a profit for its third quarter that Increases, from the same p…
- Yahoo Finance Stock Market Today: Dow, Nasdaq Rise After No Fed Rate Hike; Labcorp Blasts Off The Dow Jones index trimmed its gain Wednesday after the Fed held its key intere…
GEHC
0.438
$79.55
▲
3.89%
3 mentions
Why is GEHC moving?
▲ Why it may be rising
- barchart.com This Healthcare Stock Just Raised Its Dividend by Nearly 15%. GE HealthCare raised its quarterly dividend to $0.04 per share on Sept. 22 after Q2 revenue rose t…
- Yahoo Finance GE HealthCare Stock Eyes Breakout On Best Earnings Since Spinoff GE HealthCare separated from General Electric and began trading under GEHC in 2023.
- Yahoo Finance 2 Reasons Why GE HealthCare Stock Is Climbing After Earnings GE HealthCare points to broad-based growth across all three of its business divisions as its raises…
ALGN
0.796
$154.13
▲
2.83%
2 mentions
Why is ALGN moving?
▲ Why it may be rising
- 247wallst.com Here Are Monday’s Top Wall Street Analyst Research Calls: Align Technology, AutoNation, Estee Lauder, Harley-Davidson, HubSpot, Microsoft, Mosaic, Ryder System,…
- Nasdaq Align Technology Wins UPC Patent Case Against Angelalign (RTTNews) - Align Technology Inc. (ALGN) said the Unified Patent Court (UPC) ruled that aligner systems…
ELV
0.718
$413.6
▼
1.54%
2 mentions
Why is ELV moving?
▲ Why it may be rising
- Yahoo Finance Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q…
- Yahoo Finance Elevance Health Posts Earnings Beat, Lifts Guidance. CFO Sees a ‘Clear Path’ to Growth. Investors are continuing to watch how the insurer navigates costs in its…
ZBH
0.619
$97.35
▲
2.99%
2 mentions
Why is ZBH moving?
▲ Why it may be rising
- Nasdaq ZBH Makes Bullish Cross Above Critical Moving Average In trading on Monday, shares of Zimmer Biomet Holdings Inc (Symbol: ZBH) crossed above their 200 day movin…
- Nasdaq Zimmer Biomet Extends Limited Exclusive Distribution Agreement With THINK Surgical (RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company,…
AZN
0.617
$186.58
▼
0.04%
2 mentions
Why is AZN moving?
▲ Why it may be rising
- Nasdaq AstraZeneca: CHMP Recommends Enhertu For Approval In The EU (RTTNews) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) and Daiichi Sankyo's (4568.T) Enhertu has been…
- Nasdaq AstraZeneca's Tezspire Shows Sustained Benefits In Phase 3 Esophagitis Trial (RTTNews) - AstraZeneca (AZN) said Tuesday that full results from the Phase 3 CROSS…
▼ Why it may be falling
- Yahoo Finance AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Approved for NHS Use in England
- Investing.com AstraZeneca, Daiichi Sankyo partner with Summit on cancer trial
- CNBC Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer A drug from Amgen could give patients with an aggressive form of lung ca…
TMO
0.542
$682.65
▼
2.06%
2 mentions
Why is TMO moving?
STE
0.54
$233.35
▲
2.74%
2 mentions
Why is STE moving?
▲ Why it may be rising
- Yahoo Finance Reasons to Add STE Stock to Your Portfolio Right Now STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlo…
- Fortune Anthropic’s S-1, by the numbers: A thriving business—with a $441 billion asterisk Anthropic's business is booming. But so are its commitments.
RVTY
0.53
$151.6
▼
3.44%
2 mentions
Why is RVTY moving?
▲ Why it may be rising
- Yahoo Finance Revvity Board Declares Quarterly Dividend WALTHAM, Mass., October 30, 2026--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quart…
- Nasdaq Revvity Now #408 Largest Company, Surpassing Essex Property Trust In the latest look at the underlying components of the S&P 500 ordered by largest market c…
HCA
0.411
$467.73
▼
1.15%
2 mentions
Why is HCA moving?
▲ Why it may be rising
▼ Why it may be falling
INCY
0.29
$120.04
▼
0.29%
2 mentions
Why is INCY moving?
▲ Why it may be rising
▼ Why it may be falling
- Nasdaq Relative Strength Alert For Incyte Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One w…
- Nasdaq Genmab, Incyte Partner On Trial Of Petosemtamab Combination In KRAS G12D-Mutated Colorectal Cancer (RTTNews) - Genmab A/S (GMAB) and Incyte (INCY) have entered…
- Investing.com Incyte stock price target maintained at $152 by H.C. Wainwright on cancer drug data
UHS
0.284
$180.65
▲
2.61%
2 mentions
Why is UHS moving?
EW
0.863
$93.26
▲
1.36%
1 mention
Why is EW moving?
COR
0.84
$337.84
▲
2.12%
1 mention
Why is COR moving?
BIIB
0.818
$249.01
▼
1.82%
1 mention
Why is BIIB moving?
▲ Why it may be rising
CRL
0.807
$338.54
▼
5.81%
1 mention
Why is CRL moving?
IDXX
0.784
$671.64
▲
21.85%
1 mention
Why is IDXX moving?
HSIC
0.586
$86.62
▲
2.05%
1 mention
Why is HSIC moving?
DHR
0.44
$227.97
▼
1.83%
1 mention
Why is DHR moving?
▲ Why it may be rising
DVA
0.382
$185.74
▼
0.94%
1 mention
Why is DVA moving?
VEEV
0.382
$307.0
▼
1.90%
1 mention
Why is VEEV moving?
IQV
0.318
$258.44
▼
3.33%
1 mention
Why is IQV moving?
HUM
0.202
$410.41
▼
0.99%
1 mention
Why is HUM moving?
⚠ Legal Disclaimer
This tool is for educational purposes only. It does not constitute financial, investment, or legal advice. The sentiment scores and stock mentions shown here are derived from automated analysis of publicly available news and should not be used as the basis for any trading or investment decision. Past sentiment signals are not indicative of future stock performance. The creators of NewsToStocks accept no liability for any financial losses or decisions made based on this tool. Always consult a licensed financial advisor before making investment decisions.
📰 Data sources Stock prices via Yahoo Finance. News headlines from Reuters, Yahoo Finance, MarketWatch, CNBC, The Wall Street Journal, TechCrunch, Fortune, Business Insider, Investing.com, Nasdaq, CNN Business, and Reddit — each headline links to its original article, with the source publication tagged alongside it.
📰 Data sources Stock prices via Yahoo Finance. News headlines from Reuters, Yahoo Finance, MarketWatch, CNBC, The Wall Street Journal, TechCrunch, Fortune, Business Insider, Investing.com, Nasdaq, CNN Business, and Reddit — each headline links to its original article, with the source publication tagged alongside it.